- Home
- ONCY vs KRON Comparison
ONCY vs KRON Comparison
Compare ONCY & KRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONCY
- KRON
- Stock Information
- Founded
- ONCY 1998
- KRON 2017
- Country
- ONCY Canada
- KRON United States
- Employees
- ONCY N/A
- KRON N/A
- Industry
- ONCY Pharmaceuticals and Biotechnology
- KRON Medicinal Chemicals and Botanical Products
- Sector
- ONCY Health Care
- KRON Health Care
- Exchange
- ONCY Nasdaq
- KRON Nasdaq
- Market Cap
- ONCY 56.2M
- KRON 59.8M
- IPO Year
- ONCY 1999
- KRON 2020
- Fundamental
- Price
- ONCY $0.69
- KRON $0.99
- Analyst Decision
- ONCY Strong Buy
- KRON Buy
- Analyst Count
- ONCY 2
- KRON 3
- Target Price
- ONCY $4.00
- KRON $1.63
- AVG Volume (30 Days)
- ONCY 2.6M
- KRON 231.8K
- Earning Date
- ONCY 03-06-2025
- KRON 03-20-2025
- Dividend Yield
- ONCY N/A
- KRON N/A
- EPS Growth
- ONCY N/A
- KRON N/A
- EPS
- ONCY N/A
- KRON N/A
- Revenue
- ONCY N/A
- KRON $9,864,000.00
- Revenue This Year
- ONCY N/A
- KRON $62.21
- Revenue Next Year
- ONCY N/A
- KRON N/A
- P/E Ratio
- ONCY N/A
- KRON N/A
- Revenue Growth
- ONCY N/A
- KRON 146.48
- 52 Week Low
- ONCY $0.67
- KRON $0.69
- 52 Week High
- ONCY $1.53
- KRON $1.60
- Technical
- Relative Strength Index (RSI)
- ONCY 34.93
- KRON 47.18
- Support Level
- ONCY $0.67
- KRON $0.99
- Resistance Level
- ONCY $0.72
- KRON $1.09
- Average True Range (ATR)
- ONCY 0.05
- KRON 0.05
- MACD
- ONCY -0.01
- KRON -0.00
- Stochastic Oscillator
- ONCY 9.48
- KRON 26.42
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatment. The other projects in the company's pipeline include, Bracelet-1 for treatment of Breast Cancer, Goblet cohort-1, Goblet cohort-5 for treatment of Gastro-Intestinal Cancer among others.
About KRON Kronos Bio Inc.
Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine plan by targeting dysregulated transcription. The company operates in one business segment, the development of biopharmaceutical products.